Cardiology – Page 2

Twice-Yearly Inclisiran Transforms LDL-C Management in Adolescents with HeFH: Insights from ORION-16

By MedXY 03/10/2026

The ORION-16 trial demonstrates that inclisiran, a twice-yearly siRNA therapy, significantly and safely reduces LDL cholesterol in adolescents with heterozygous familial hypercholesterolaemia, offering a promising solution for long-term adherence and cardiovascular risk reduction in this high-risk pediatric population.

Cardiology Clinical Updates news

Clinical Factors and Biomarkers During Pregnancy and Risk of Cardiovascular Disease: Leveraging the ‘Natural Stress Test’

By MedXY 03/10/2026

This review synthesizes findings on how pregnancy biomarkers, particularly sFlt-1 and hs-cTnI, serve as early indicators of long-term maternal cardiovascular risk, offering a unique window for sex-specific prevention.

Cardiology news

Beyond the Culprit: Unmasking the Prevalence and Fate of Silent Plaque Ruptures in Non-Infarct-Related Arteries

By MedXY 03/10/2026

A landmark multimodality imaging study reveals that silent plaque ruptures occur in 12% of non-obstructive lesions in AMI patients. Over 50% of these ruptures heal within a year, highlighting the dynamic nature of coronary atherosclerosis and the importance of systemic secondary prevention strategies.

Cardiology news Pediatrics

Misaligned Urgency: Why Status Exceptions May Be Paradoxically Lowering Priority for the Sickest Children in Heart Transplantation

By MedXY 03/10/2026

A large-scale analysis of 6,026 pediatric heart transplant candidates reveals that status exceptions often prioritize patients with lower mortality risk than those meeting standard criteria, highlighting a significant misalignment in the U.S. allocation system that the National Heart Review Board has yet to resolve.

Cardiology Clinical Updates news

Intramuscular Adipose Tissue Accumulation as a Key Determinant of Muscle Dysfunction in Peripheral Artery Disease

By MedXY 03/10/2026

This review synthesizes evidence that intramuscular adipose tissue (IMAT) accumulation, driven by fibroadipogenic progenitors, is a primary driver of limb dysfunction in PAD/CLTI, identifying IMAT as a novel therapeutic target.

Cardiology Critical Care news

Etiology, Management, and Outcomes of Society for Cardiovascular Angiography and Interventions Stage B Cardiogenic Shock

By MedXY 03/10/2026

This clinical analysis of 500 patients identifies heart failure and arrhythmias as the primary causes of SCAI Stage B shock. Key findings highlight acute kidney injury and diuretic resistance as significant predictors of clinical deterioration and the need for escalation of care.

Cardiology news Oncology

GnRH Antagonists May Spare the Heart: Evidence of Reduced Coronary Plaque Progression in Prostate Cancer Patients

By MedXY 03/09/2026

A randomized clinical trial indicates that the GnRH agonist leuprolide significantly accelerates coronary plaque progression compared to the antagonist relugolix in men with prostate cancer, suggesting a potential biological mechanism for differential cardiovascular risk between ADT classes.

Cardiology Diabetes & Endocrinology news

Semaglutide Drives Vascular Regeneration: The SEMA-VR CardioLink-15 Trial Reveals a Shift in Progenitor Cell Flux

By MedXY 03/09/2026

The SEMA-VR CardioLink-15 trial demonstrates that semaglutide shifts bone marrow-derived progenitor cells toward an anti-inflammatory, pro-regenerative profile, potentially enhancing endogenous vessel repair in high-risk cardiovascular patients beyond traditional glycemic control.

Cardiology Internal Medicine news

Varenicline and Ventricular Ectopy After Myocardial Infarction: A Randomized Phase 2 Study

By MedXY 03/09/2026

This phase 2 trial demonstrates that varenicline, a partial nAChR agonist, significantly reduces premature ventricular complexes and nonsustained ventricular tachycardia in post-myocardial infarction patients, offering a novel therapeutic target for cardiac arrhythmias.

Cardiology news Respiratory

From Compensation to Collapse: How Cardiac Myofibroblasts and UCP2 Genetic Variants Dictate Right Ventricular Fate in PAH

By MedXY 03/09/2026

This study identifies the transition of cardiac fibroblasts to myofibroblasts as a critical driver of right ventricular failure in PAH, highlighting the role of UCP2 deficiency and the rs659366 SNP as key clinical indicators of decompensation.

Cardiology news

Beyond the Gradient: Invasive Exercise Hemodynamics Confirm Discordant Low-Gradient Aortic Stenosis as a High-Risk Phenotype

By MedXY 03/09/2026

A pivotal study using invasive exercise hemodynamics reveals that discordant low-gradient aortic stenosis behaves similarly to high-gradient severe disease, often masking underlying heart failure with preserved ejection fraction (HFpEF) physiology and necessitating earlier clinical intervention.

Cardiology news

Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction: The APERITIF Randomized Clinical Trial

By MedXY 03/09/2026

The APERITIF trial explored adding low-dose rivaroxaban to standard dual antiplatelet therapy to prevent heart clots after an anterior heart attack. While the addition did not significantly reduce thrombus formation, it did increase minor bleeding risk, suggesting a need for cautious clinical application.

Cardiology Diabetes & Endocrinology news

Taurochenodeoxycholic Acid: A Novel Metabolic Sentinel Reversing Obesity-Induced Endothelial Dysfunction via the FXR-PHB1-ATF4 Axis

By MedXY 03/09/2026

This study identifies TCDCA as a key metabolite that restores endothelial function in obesity. By activating the endothelial FXR-PHB1-ATF4 pathway, TCDCA enhances serine metabolism, offering a promising therapeutic strategy to mitigate cardiovascular risk in obese populations.

Cardiology General Surgery news

The Ross Procedure Renaissance: Why Surgical Volume is the Critical Determinant of Patient Survival

By MedXY 03/09/2026

A comprehensive analysis of North American data reveals a significant resurgence in the Ross procedure for young adults, while highlighting a stark correlation between center volume and operative mortality, suggesting a critical threshold of 10 cases per year for optimal outcomes.

Cardiology Diabetes & Endocrinology news Urology

Testosterone and Weight Loss: Decoding the Link Between Sex Hormones and Cardiovascular Risk in Men with Type 2 Diabetes

By MedXY 03/09/2026

A longitudinal analysis of the Look AHEAD trial demonstrates that baseline testosterone and weight loss-induced changes in SHBG significantly modulate cardiovascular risk in men with type 2 diabetes, highlighting the critical role of hormonal health in metabolic management.

AI Cardiology Clinical Updates news

Precision Prediction of Incident Heart Failure: The Clinical Integration of AI-Enabled Electrocardiography

By MedXY 03/09/2026

This review evaluates the breakthrough ECG2HF model, a publicly available AI tool that outperforms standard clinical scores in predicting 10-year heart failure risk using 12-lead ECG waveforms.

Cardiology Neurology news

Long-Term Efficacy and Safety of Transcatheter Patent Foramen Ovale Closure: A 20-Year Follow-Up Study

By MedXY 03/09/2026

A 20-year follow-up study of 130 patients demonstrates that transcatheter PFO closure is highly effective in preventing recurrent strokes, though long-term antithrombotic therapy increases bleeding risks, particularly in women.

Cardiology news

Inhibiting Myeloid-PlexinD1: A Novel Strategy to Stabilize Atherosclerosis at High-Risk Vascular Bifurcations

By MedXY 03/09/2026

Research reveals that PlexinD1 mediates macrophage-driven inflammation in response to disturbed blood flow. By targeting this pathway, scientists have successfully attenuated plaque progression in preclinical models, paving the way for advanced diagnostic imaging and precision therapies in cardiovascular medicine.

Cardiology news Radiology

Long-Term Superiority of Intravascular Imaging: 5-Year Results from the RENOVATE-COMPLEX-PCI Trial

By MedXY 03/09/2026

A 5-year follow-up of the RENOVATE-COMPLEX-PCI trial demonstrates that intravascular imaging-guided PCI significantly reduces major adverse cardiac events by 32% compared to angiography alone in complex lesions, highlighting the long-term clinical benefits of procedural optimization.

Cardiology Clinical Updates news

Genotype-Phenotype Divergence in Hypertrophic Cardiomyopathy: Deciphering the Trajectories of Sarcomeric and Nonsarcomeric Disease

By MedXY 03/09/2026

This review analyzes the SHaRe registry data, revealing that sarcomeric HCM represents a more aggressive clinical phenotype with earlier onset and higher HCM-related mortality compared to nonsarcomeric cases, which are more heavily influenced by modifiable metabolic comorbidities.